Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Share-based Compensation: 2015-2024

Historic Share-based Compensation for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to $34.0 million.

  • Anaptysbio's Share-based Compensation rose 11.82% to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.8 million, marking a year-over-year increase of 5.22%. This contributed to the annual value of $34.0 million for FY2024, which is 2.54% up from last year.
  • Anaptysbio's Share-based Compensation amounted to $34.0 million in FY2024, which was up 2.54% from $33.2 million recorded in FY2023.
  • In the past 5 years, Anaptysbio's Share-based Compensation ranged from a high of $34.0 million in FY2024 and a low of $11.5 million during FY2020.
  • Its 3-year average for Share-based Compensation is $31.5 million, with a median of $33.2 million in 2023.
  • Per our database at Business Quant, Anaptysbio's Share-based Compensation declined by 7.35% in 2020 and then skyrocketed by 78.25% in 2022.
  • Anaptysbio's Share-based Compensation (Yearly) stood at $11.5 million in 2020, then soared by 33.46% to $15.3 million in 2021, then spiked by 78.25% to $27.4 million in 2022, then increased by 21.38% to $33.2 million in 2023, then climbed by 2.54% to $34.0 million in 2024.